ONCOS-102
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ONCOS-102, covering 2014-10-02 to 2022-12-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies [Phase 1, Phase 2]